ESC 365 - Icosapent ethyl by baseline small dense low-density lipoprotein cholesterol: an analysis of REDUCE-IT

ESC Professional Premium Access

Icosapent ethyl by baseline small dense low-density lipoprotein cholesterol: an analysis of REDUCE-IT

Session: Identification and risk stratification of relevant coronary artery disease in clinical practice

Topic: Pharmacotherapy

Speaker: Doctor R. Aggarwal (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

3 more presentations in this session

State-of-the-art lecture on identification and risk stratification of relevant coronary artery disease in clinical practice

Speaker: Professor P. Steg (Paris, FR)

Investigating the influence of possible liver fibrosis on mortality in patients with coronary artery disease - a post-hoc ISCHEMIA trial analysis

Speaker: Doctor T. Caldonazo (Jena, DE)

Electrocardiogram-based artificial intelligence to identify prevalent coronary artery disease

Speaker: Doctor S. Kany (Hamburg, DE)

Access the full session

Identification and risk stratification of relevant coronary artery disease in clinical practice

Speakers: Doctor R. Aggarwal, Professor P. Steg, Doctor T. Caldonazo, Doctor S. Kany

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources